NICM
PTCT icon

Neo Ivy Capital Management’s PTC Therapeutics PTCT Stock Holding History

Neo Ivy Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,880
Closed -$1.16M – 498
2025
Q3 		$1.16M Sell
18,880
-4,187
-18% -$218K 0.28% 126
2025
Q2 		$1.13M Sell
23,067
-13,179
-36% -$626K 0.36% 101
2025
Q1 		$1.85M Buy
+36,246
New +$1.81M 0.59% 76
2024
Q3 		– Sell
-40,708
Closed -$1.25M – 372
2024
Q2 		$1.25M Buy
+40,708
New +$1.32M 0.24% 132
2023
Q4 		– Sell
-11,800
Closed -$264K – 426
2023
Q3 		$264K Buy
11,800
+11,335
+2,438% +$422K 0.12% 215
2023
Q2 		$19K Buy
+465
New +$22.8K 0.01% 268
2022
Q4 		$234K Buy
+6,132
New +$255K 0.16% 215
2022
Q3 		– Sell
-2,969
Closed -$118K – 512
2022
Q2 		$118K Buy
+2,969
New +$104K 0.32% 133
2021
Q4 		– Sell
-1,320
Closed -$67K – 591
2021
Q3 		$67K Buy
+1,320
New +$54.2K 0.08% 296
2020
Q3 		– Sell
-1,320
Closed -$67K – 587
2020
Q2 		$67K Buy
1,320
+292
+28% +$14.3K 0.08% 296
2020
Q1 		$46K Sell
1,028
-585
-36% -$29.5K 0.07% 323
2019
Q4 		$77K Buy
+1,613
New +$68.5K 0.09% 195
2019
Q3 		– Sell
-25,114
Closed -$1.13M – 373
2019
Q2 		$1.13M Buy
+25,114
New +$992K 0.64% 61

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Neo Ivy Capital Management's PTCT Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of PTC Therapeutics (PTCT) in Q4 2025, closing a stake of 18,880 shares — an estimated $1.16M sold.

Neo Ivy Capital Management first reported a position in PTCT in Q2 2019 and held it in 13 quarters. The position peaked at $1.85M in Q1 2025. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining PTC Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 18,880 PTC Therapeutics shares in Q4 2025, an estimated $1.16M.
  • Neo Ivy Capital Management first reported a position in PTC Therapeutics in Q2 2019 and held it in 13 quarters.
  • Neo Ivy Capital Management's PTC Therapeutics position peaked at $1.85M in Q1 2025.
  • 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.